Why Farbe Firma is the Leading Injectable Manufacturer in Grenada
Why Farbe Firma is the Leading Injectable Manufacturer in Grenada
Last Updated: 20 September 2026
TL;DR: Grenada's two drug statutes register people and premises, not products. We read both in full and found no product register. Grenada does publish a list, but it is a list of pharmacopoeias rather than of agencies, so asking whether India's CDSCO appears on it is asking about the wrong noun. The money sits in OECS pooled procurement, whose manufacturer form asks for a GMP or ISO certificate and names no issuing authority. The regional reliance route, CARPHA's CRS, is the one place where Indian certification does not travel.
Key Takeaways
The governing instruments are the Pharmacy Act, Cap. 241, enacted as Act 25 of 1987 and commenced 1 December 1988, and the Food and Drugs Act, Cap. 110, enacted as Act 14 of 1986 and commenced 11 April 1986. The Pharmacy Act registers pharmacists and premises; neither statute creates a product register.
The Food and Drugs Act's revised edition states in terms that it has no subsidiary legislation, and the Pharmacy Act's own list of subsidiary legislation contains a single item, the Fees Regulations. The power to regulate pharmaceutical imports therefore appears to sit unexercised.
Where no standard is prescribed, a drug is measured against the pharmacopoeias in the Second Schedule: Ph.Int., BP, USP, BPC, the Canadian Formulary, the National Formulary, BNF and the Codex Francais. These are compendia, not regulatory agencies, and the Indian Pharmacopoeia is not among the names.
The two regional bodies pull in opposite directions. OECS pooled procurement is agency-agnostic and asks for a GMP or ISO certificate without naming an issuer. CARPHA's Caribbean Regulatory System is agency-specific, omits CDSCO from its published reference list, and requires a GMP certificate issued by a reference authority.
Introduction: What an Injectable Manufacturer in Grenada Actually Has to Clear
Grenada is small enough that exporters tend to assume it borrows someone else's rulebook, and large enough in the Eastern Caribbean that the assumption gets expensive. The accurate starting point is that Grenada has its own medicines legislation, that we read both statutes end to end, and that neither of them creates a marketing authorisation. What they create is a licensed importer, registered premises, a registered pharmacist and a set of post-market offences for anything sold below standard.
One honest limit belongs at the front of this. The national laws portal was unreachable when this was researched, and the PAHO pharmaceutical country profile for Grenada returned a server error and was never opened. So we say that we read two statutes and found no product register, not that Grenada has no registration requirement anywhere in its statute book. The difference between those two sentences is the difference between evidence and a guess.
What Sets a World-Class Injectable Manufacturer in Grenada Apart
The first discipline is noticing which noun a published list actually contains. Grenada does publish a list in the Food and Drugs Act, and an exporter skimming for reassurance will read it as a list of accepted regulators. It is not. It is a schedule of pharmacopoeias used to judge whether a drug meets a standard when no standard has been prescribed. The Indian Pharmacopoeia is absent from it, and the Act nowhere says the Indian Pharmacopoeia is rejected.
The second is treating the import provision as what it says. Section 33(2) of the Food and Drugs Act conditions importation on the article conforming to the law of its country of manufacture and being accompanied by an authentic document in prescribed form certifying as much. We could not locate the prescribed form, and the word permit does not appear in the provision we read. A supplier should prepare the certification and ask the buyer which form it takes.
Quality Systems Behind Every Batch Shipped to Grenada
Farbe Firma manufactures sterile injectables under WHO-GMP certification with ISO Class 5 aseptic filling in Gujarat, India, supported by CTD and ACTD dossiers, HPLC and GC assay, LAL endotoxin testing, Karl Fischer moisture determination and ICH Q1A and Q1B stability programmes. For the Caribbean the stability question is not incidental: the regional reliance route specifies zone IVB conditions, and hot, humid long-term data is what a serious Grenada file is built on.
Documentation language is the quiet second requirement. The regional system requires all documentation in English, which happens to be the language of business in Grenada as well, so a single English master file serves the importer, the tender and the reliance route without translation risk. Where evidence has to be re-keyed between languages, errors enter; where it does not, the same certificate can be produced unchanged to every party that asks.
Why Farbe Firma is the Trusted Injectable Manufacturer in Grenada for Global Buyers
The commercially useful fact is that the two regional routes ask different questions, and only one of them is a certificate test an Indian manufacturer passes on its own papers. The OECS Pharmaceutical Procurement Service, headquartered in Castries, requires products to conform to WHO GMP, GSP and GDP standards and asks the manufacturer to attach a certificate of GMP or ISO certification. It names no issuing authority, publishes no list of accepted regulators, and marks the WHO-format certificate of a pharmaceutical product as optional.
CARPHA's Caribbean Regulatory System is the opposite. It operates a reliance and verification pathway, issues a recommendation rather than an authorisation, and reviews in roughly four to eight weeks once eligibility is met. Its published list of reference authorities for medicines runs to around forty agencies and does not include CDSCO, and it requires the most recent GMP certificate issued by a reference authority. An Indian-only certificate does not travel on that route, and we would rather say so plainly than let a buyer discover it late.
Two commercial facts finish the picture. Grenada is listed as eligible for HIV and tuberculosis financing on the Global Fund's 2026 eligibility list through the small island economy exception, so this is not a market that has priced donors out, though eligibility never guarantees an allocation. And out-of-pocket spending has been reported at over half of total health expenditure, which means the private pharmacy channel is not a rounding error beside the tender but a parallel market of comparable weight.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Do I need to register my injectable before it can be sold in Grenada?
We read the Pharmacy Act and the Food and Drugs Act in full and found no product-registration provision in either. We did not complete a sweep of the whole statute book and the national laws portal was unreachable, so the honest form of the answer is that the two governing statutes register people and premises rather than products, and that the importer, the premises and the pharmacist are what carry registration obligations.
Is India's CDSCO on a recognised or reference authority list for Grenada?
Not at the regional reliance layer. The Caribbean Regulatory System publishes a list of reference authorities for medicines and CDSCO is not on it, and its 2017 eligibility list of ten jurisdictions omits India as well. Nationally the question does not arise, because the only list Grenada publishes is of pharmacopoeias. And CDSCO's own WHO listing is recorded with a vaccines scope, not a medicines one.
What are the registration fees and review timelines?
There is no located national product registration to charge for or to time. The Pharmacy Act's schedule does print a wholesaler distributor of pharmaceuticals annual registration fee of two hundred dollars, with no currency code printed alongside it, and we will not guess which dollar that is. The one verified timeline is the regional reliance review at roughly four to eight weeks.
Who actually buys, and do I need a local counterparty?
Yes, on the evidence of the tender paperwork itself. OECS pooled procurement invites only prequalified tenderers from its suppliers' directory, and prequalification uses a two-part form in which a distributor completes one section and asks each manufacturer to complete the other, with letters of authorisation. Whether a manufacturer can tender in its own right is not something we could establish from the form.
What clinical demand should an injectables supplier actually plan for?
A non-communicable disease profile, emphatically. Non-communicable diseases accounted for 82.8 per cent of deaths in Grenada in 2019, with cardiovascular disease, diabetes and cancers the leading causes of death and disability. Reported hypertension prevalence was 24.3 per cent and diabetes 11.1 per cent. That points at cardiovascular, endocrine, anaesthesia and oncology support injectables rather than a communicable disease basket.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments